Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Dr Reddy’s Laboratories ( (RDY) ).
On July 24, 2025, Dr. Reddy’s Laboratories held its 41st Annual General Meeting (AGM) via video conferencing, where key business and financial matters were discussed. The meeting included the adoption of the company’s audited financial statements for the year ending March 31, 2025, and the declaration of a dividend of Rs. 8 per equity share. Additionally, the re-appointment of Mr. G V Prasad as a director and Co-Chairman and Managing Director was approved. The AGM also covered special business items such as the approval of remuneration for cost auditors and the appointment of a new secretarial auditor. The meeting facilitated electronic voting for members to ensure a transparent decision-making process.
The most recent analyst rating on (RDY) stock is a Buy with a $17.40 price target. To see the full list of analyst forecasts on Dr Reddy’s Laboratories stock, see the RDY Stock Forecast page.
Spark’s Take on RDY Stock
According to Spark, TipRanks’ AI Analyst, RDY is a Neutral.
The overall stock score of 68 reflects strong financial performance and reasonable valuation, offset by bearish technical indicators. The company’s solid balance sheet and consistent revenue growth bolster its financial health, but short-term market momentum suggests caution.
To see Spark’s full report on RDY stock, click here.
More about Dr Reddy’s Laboratories
Dr. Reddy’s Laboratories Limited is a prominent pharmaceutical company based in Hyderabad, India. It specializes in the development and manufacturing of a wide range of pharmaceutical products, including generic medicines, active pharmaceutical ingredients, and biosimilars. The company focuses on providing affordable and innovative healthcare solutions globally.
Average Trading Volume: 1,580,443
Technical Sentiment Signal: Strong Buy
Current Market Cap: $12.2B
See more data about RDY stock on TipRanks’ Stock Analysis page.